PFE Pfizer

$25.22 -2.89%

Healthcare · Pharmaceutical Preparations

Pfizer (PFE) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $143.7 billion. Shares last traded at $25.22, 12.2% below their 52-week high. Over the past year the stock is up 5.3%. PFE trades at a price-to-earnings ratio of 18.50, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 12.4%, above the peer median of -0.1%. Revenue declined 1.6% year over year. The shares yield 6.8% in dividends.

Market Cap

$143.7B

Shares Out

5.70B

EPS (TTM)

$3.67

P/E Ratio

6.87

P/S Ratio

2.30

P/B Ratio

1.60

Dividend / Share

$1.72

Dividend Yield

6.82%

52-Week High

$28.74

52-Week Low

$23.10

Volume

4.8M

Avg Vol (3m)

1.9M

Performance

-3.52%

-1.79%

-8.04%

-1.02%

YTD

+0.16%

+5.30%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

38.05

SMA (50)

$26.25

SMA (200)

$25.88

Price vs SMA50

-3.93%

Price vs SMA200

-2.54%

ATR (14)

$0.52

Financials

Revenue

$62.6B

Net Income

$7.8B

Gross Margin

—

Operating Margin

—

Net Margin

12.4%

Return on Equity

8.6%

Return on Assets

3.7%

Current Ratio

1.25

Debt / Equity

0.67

Revenue Growth (YoY)

-1.6%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.47	2026-05-05
FY 2025	$1.36	2026-02-26
Q3 2025	$1.65	2025-11-04
Q2 2025	$1.03	2025-08-05
Q1 2026	$0.52	2026-05-05
FY 2025	$1.41	2026-02-26

Full earnings history →

Pharmaceutical Preparations peers

PFE vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

18.50 / 16.82 med

+10% premium

P/S vs peers

2.30 / 3.54 med

-35% discount

Net margin vs peers

12.4% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.